Navigation Links
Revelation Of Cancer Agent Could Help In Developing Effective Cancer Drugs

Scientists have exposed the mystery of an enzyme, which is believed to play a key role in the development of many types of cancer. // They further added that the revelation could be of immensely helpful for the development of more effective cancer drugs.

The over-activity of an enzyme called telomerase is believed to contribute to the unchecked growth of as many as 90 percent of human tumors. A lack of detailed information regarding its structure had hindered attempts to develop agents to block its effect.

Researchers led by Thomas Cech at the University of Colorado now claim to have cracked the structure of an essential part of this enzyme, the online edition of BBC News reported.

Telomerase plays a key role in the development of the human embryo during pregnancy, by extending important areas at the tips of chromosomes called telomeres. In most healthy adult cells, the enzyme is completely shut down.

However, cancer cells find a way to activate telomerase - triggering uncontrolled cell division. Developing therapies that block the action of telomerase could be the key to treat many types of cancer.

--Edited IANS
'"/>




Page: 1

Related medicine news :

1. Malignant Mesothelioma – A New Genetic Revelation
2. Fibroids unlikely to Turn Cancerous
3. Virus Level could Predict Cervical Cancer Risk
4. Cancer Doctors Okays Controversial Prostate Therapy
5. Potential New Cancer Gene Identified
6. Consensus on "Combination Therapy" for Breast Cancer
7. Cancers of Colon & Rectum linked to Cigarette Smoking
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. The Cancer Rumour mill working over time
10. Cancer drugs in development nearly doubled since 1995
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... , ... September 22, 2017 , ... ... and financial setbacks, a senior finds a new lease on life with assistance ... thousands of people resolve their problem with unsecured debt. The senior is one ...
(Date:9/22/2017)... ... ... “Cursed with a Curse: The Truth about Tithing”: a ... when breaking free from this misconception. “Cursed with a Curse: The Truth about ... Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and thought-provoking ...
(Date:9/22/2017)... ... ... of the Spirit: “Love””: a delightful adventure of two friends who play and ... “Love”” is the creation of published author, Halimah Jones, who was born and raised ... avid writer, her inspiration for “Fruit of the Spirit: “Love”” blossomed from her background ...
(Date:9/21/2017)... CA (PRWEB) , ... September 21, 2017 , ... With ... so fun and easy to do. Users can select from up to two layers ... with a click of a mouse all within Final Cut Pro X. ...
(Date:9/21/2017)... ... 21, 2017 , ... Promotional Communication:, Keeping Up with FDA’s ... the competitive world of drug and device marketing and promotion, drug and devicemakers ... , The FDA has issued two draft guidances that are the closest thing ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... MIRAGE, Calif. , Sept. 7, 2017  For nearly two decades, ... service in the Assisted Reproduction Insurance industry. Today, New Life Agency announces ... fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology: